Seroepidemiology of group I human coronaviruses in children

Xiuping Shao, Xiaojie Guo, Frank Esper, Carla Weibel, Jeffrey Kahn

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Recently, several new human coronaviruses have been identified. Objectives: To define the seroepidemiology of group I human coronaviruses. Study design: A recombinant protein enzyme linked immunosorbent assay (ELISA) based on portions of the nucleocapsid protein of group I human coronaviruses was developed and was used to screen serum from 243 children and young adults. Results: For HCoV-229E, the percentages of seropositive individuals were 57.1% for infants <2 months old; 38.9% for infants 2-3 months old; 4.7% for infants 4-5 months old; 42.9-50.0% for infants 6-12 months old; 34.8-62.5% for individuals 1-20 years old. For HCoV-NL63, the percentages of seropositive individuals were 45.2% for infants <2 months old; 11.1% for infants 2-3 months old; 4.7% for infants 4-5 months old; 28.6-40.0% for infants 6-12 months old; 25.0-70.3% for individuals 1-20 years old. Conclusions: Infection with these viruses is common in childhood though the prevalence of these viruses may vary from year to year.

Original languageEnglish (US)
Pages (from-to)207-213
Number of pages7
JournalJournal of Clinical Virology
Volume40
Issue number3
DOIs
StatePublished - Nov 2007

Fingerprint

Coronavirus
Human Coronavirus NL63
Nucleocapsid Proteins
Virus Diseases
Recombinant Proteins
Young Adult
Enzyme-Linked Immunosorbent Assay
Viruses
Serum

Keywords

  • Human coronavirus
  • Nucleocapsid
  • Seroepidemiology

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Seroepidemiology of group I human coronaviruses in children. / Shao, Xiuping; Guo, Xiaojie; Esper, Frank; Weibel, Carla; Kahn, Jeffrey.

In: Journal of Clinical Virology, Vol. 40, No. 3, 11.2007, p. 207-213.

Research output: Contribution to journalArticle

Shao, Xiuping ; Guo, Xiaojie ; Esper, Frank ; Weibel, Carla ; Kahn, Jeffrey. / Seroepidemiology of group I human coronaviruses in children. In: Journal of Clinical Virology. 2007 ; Vol. 40, No. 3. pp. 207-213.
@article{0fb24f783e46484dad4bbc1758c05437,
title = "Seroepidemiology of group I human coronaviruses in children",
abstract = "Background: Recently, several new human coronaviruses have been identified. Objectives: To define the seroepidemiology of group I human coronaviruses. Study design: A recombinant protein enzyme linked immunosorbent assay (ELISA) based on portions of the nucleocapsid protein of group I human coronaviruses was developed and was used to screen serum from 243 children and young adults. Results: For HCoV-229E, the percentages of seropositive individuals were 57.1{\%} for infants <2 months old; 38.9{\%} for infants 2-3 months old; 4.7{\%} for infants 4-5 months old; 42.9-50.0{\%} for infants 6-12 months old; 34.8-62.5{\%} for individuals 1-20 years old. For HCoV-NL63, the percentages of seropositive individuals were 45.2{\%} for infants <2 months old; 11.1{\%} for infants 2-3 months old; 4.7{\%} for infants 4-5 months old; 28.6-40.0{\%} for infants 6-12 months old; 25.0-70.3{\%} for individuals 1-20 years old. Conclusions: Infection with these viruses is common in childhood though the prevalence of these viruses may vary from year to year.",
keywords = "Human coronavirus, Nucleocapsid, Seroepidemiology",
author = "Xiuping Shao and Xiaojie Guo and Frank Esper and Carla Weibel and Jeffrey Kahn",
year = "2007",
month = "11",
doi = "10.1016/j.jcv.2007.08.007",
language = "English (US)",
volume = "40",
pages = "207--213",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Seroepidemiology of group I human coronaviruses in children

AU - Shao, Xiuping

AU - Guo, Xiaojie

AU - Esper, Frank

AU - Weibel, Carla

AU - Kahn, Jeffrey

PY - 2007/11

Y1 - 2007/11

N2 - Background: Recently, several new human coronaviruses have been identified. Objectives: To define the seroepidemiology of group I human coronaviruses. Study design: A recombinant protein enzyme linked immunosorbent assay (ELISA) based on portions of the nucleocapsid protein of group I human coronaviruses was developed and was used to screen serum from 243 children and young adults. Results: For HCoV-229E, the percentages of seropositive individuals were 57.1% for infants <2 months old; 38.9% for infants 2-3 months old; 4.7% for infants 4-5 months old; 42.9-50.0% for infants 6-12 months old; 34.8-62.5% for individuals 1-20 years old. For HCoV-NL63, the percentages of seropositive individuals were 45.2% for infants <2 months old; 11.1% for infants 2-3 months old; 4.7% for infants 4-5 months old; 28.6-40.0% for infants 6-12 months old; 25.0-70.3% for individuals 1-20 years old. Conclusions: Infection with these viruses is common in childhood though the prevalence of these viruses may vary from year to year.

AB - Background: Recently, several new human coronaviruses have been identified. Objectives: To define the seroepidemiology of group I human coronaviruses. Study design: A recombinant protein enzyme linked immunosorbent assay (ELISA) based on portions of the nucleocapsid protein of group I human coronaviruses was developed and was used to screen serum from 243 children and young adults. Results: For HCoV-229E, the percentages of seropositive individuals were 57.1% for infants <2 months old; 38.9% for infants 2-3 months old; 4.7% for infants 4-5 months old; 42.9-50.0% for infants 6-12 months old; 34.8-62.5% for individuals 1-20 years old. For HCoV-NL63, the percentages of seropositive individuals were 45.2% for infants <2 months old; 11.1% for infants 2-3 months old; 4.7% for infants 4-5 months old; 28.6-40.0% for infants 6-12 months old; 25.0-70.3% for individuals 1-20 years old. Conclusions: Infection with these viruses is common in childhood though the prevalence of these viruses may vary from year to year.

KW - Human coronavirus

KW - Nucleocapsid

KW - Seroepidemiology

UR - http://www.scopus.com/inward/record.url?scp=35148866736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35148866736&partnerID=8YFLogxK

U2 - 10.1016/j.jcv.2007.08.007

DO - 10.1016/j.jcv.2007.08.007

M3 - Article

C2 - 17889596

AN - SCOPUS:35148866736

VL - 40

SP - 207

EP - 213

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

IS - 3

ER -